Skip to main content

Advertisement

Springer Nature Link
Log in

C9ORF72 Mutations in Neurodegenerative Diseases

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Recent works have demonstrated an expansion of the GGGGCC hexanucleotide repeat in the first intron of chromosome 9 open reading frame 72 (C9ORF72), encoding an unknown C9ORF72 protein, which was responsible for an unprecedented large proportion of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) cases of European ancestry. C9ORF72 is expressed in most tissues including the brain. Emerging evidence has demonstrated that C9ORF72 mutations could reduce the level of C9ORF72 variant 1, which may influence protein expression and the formation of nuclear RNA foci. The spectrum of mutations is broad and provides new insight into neurological diseases. Clinical manifestations of diseases related with C9ORF72 mutations can vary from FTD, ALS, primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), Huntington disease-like syndrome (HDL syndrome), to Alzheimer's disease. In this article, we will review the brief characterizations of the C9ORF72 gene, the expansion mutations, the related disorders, and their features, followed by a discussion of the deficiency knowledge of C9ORF72 mutations. Based on the possible pathological mechanisms of C9ORF72 mutations in ALS and FTD, we can find new targets for the treatment of C9ORF72 mutation-related diseases. Future studies into the mechanisms, taking into consideration the discovery of those disorders, will significantly accelerate new discoveries in this field, including targeting identification of new therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS–FTD. Neuron 72(2):257–268. doi:10.1016/j.neuron.2011.09.010

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245–256. doi:10.1016/j.neuron.2011.09.011

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Dejesus-Hernandez M, Rayaprolu S, Soto-Ortolaza AI, Rutherford NJ, Heckman MG, Traynor S, Strongosky A, Graff-Radford N, Van Gerpen J, Uitti RJ, Shih JJ, Lin SC, Wszolek ZK, Rademakers R, Ross OA (2013) Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism & related disorders 19(2):198–201. doi:10.1016/j.parkreldis.2012.09.013

    Article  Google Scholar 

  4. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL, 3rd, Mackenzie IR, Petersen RC, Strong MJ, Miller BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R (2012) Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 33 (12):2950 e2955-2957. doi:10.1016/j.neurobiolaging.2012.07.005

  5. Takada LT, Pimentel ML, Dejesus-Hernandez M, Fong JC, Yokoyama JS, Karydas A, Thibodeau MP, Rutherford NJ, Baker MC, Lomen-Hoerth C, Rademakers R, Miller BL (2012) Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation. Archives of neurology 69(9):1149–1153. doi:10.1001/archneurol.2012.650

    Article  PubMed Central  PubMed  Google Scholar 

  6. van Rheenen W, van Blitterswijk M, Huisman MH, Vlam L, van Doormaal PT, Seelen M, Medic J, Dooijes D, de Visser M, van der Kooi AJ, Raaphorst J, Schelhaas HJ, van der Pol WL, Veldink JH, van den Berg LH (2012) Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 79(9):878–882. doi:10.1212/WNL.0b013e3182661d14

    Article  PubMed  Google Scholar 

  7. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DM, Pickering-Brown SM (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain: a journal of neurology 135(Pt 3):693–708. doi:10.1093/brain/awr355

    Article  Google Scholar 

  8. Kohli MA, John-Williams K, Rajbhandary R, Naj A, Whitehead P, Hamilton K, Carney RM, Wright C, Crocco E, Gwirtzman HE, Lang R, Beecham G, Martin ER, Gilbert J, Benatar M, Small GW, Mash D, Byrd G, Haines JL, Pericak-Vance MA, Zuchner S (2013) Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians. Neurobiol Aging 34(5):1519.e5–1519.e12. doi:10.1016/j.neurobiolaging.2012.10.003

    Google Scholar 

  9. Ilse Gijselinck TVL, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Lancet neurology 11(1):11. doi:10.1016/S1474-4422(11)70261-7

    Google Scholar 

  10. Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K (2012) Dystrophic neurites express C9orf72 in Alzheimer's disease brains. Alzheimer's research & therapy 4(4):33. doi:10.1186/alzrt136

    Article  CAS  Google Scholar 

  11. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, de Graaf JR, de Koning I, van Schoor NM, Deeg DJ, Smits M, Raaphorst J, van den Berg LH, Schelhaas HJ, De Die-Smulders CE, Majoor-Krakauer D, Rozemuller AJ, Willemsen R, Pijnenburg YA, Heutink P, van Swieten JC (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain: a journal of neurology 135(Pt 3):723–735. doi:10.1093/brain/awr353

    Article  Google Scholar 

  12. Gomez-Tortosa E, Gallego J, Guerrero-Lopez R, Marcos A, Gil-Neciga E, Sainz MJ, Diaz A, Franco-Macias E, Trujillo-Tiebas MJ, Ayuso C, Perez-Perez J (2013) C9ORF72 hexanucleotide expansions of 20–22 repeats are associated with frontotemporal deterioration. Neurology 80(4):366–370. doi:10.1212/WNL.0b013e31827f08ea

    Article  CAS  PubMed  Google Scholar 

  13. van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Baumer V, Maes G, Corsmit E, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, de Mendonca A, Miltenberger-Miltenyi G, Pereira S, Pimentel J, Nacmias B, Bagnoli S, Sorbi S, Graff C, Chiang HH, Westerlund M, Sanchez-Valle R, Llado A, Gelpi E, Santana I, Almeida MR, Santiago B, Frisoni G, Zanetti O, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schols L, Heneka MT, Jessen F, Matej R, Parobkova E, Kovacs GG, Strobel T, Sarafov S, Tournev I, Jordanova A, Danek A, Arzberger T, Fabrizi GM, Testi S, Salmon E, Santens P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C (2013) A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Human mutation 34(2):363–373. doi:10.1002/humu.22244

    Article  PubMed Central  PubMed  Google Scholar 

  14. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O, Chromosome ALSFTDC, FFA F r n o, Consortium I, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, Van Deerlin VM, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, Le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet neurology 11(4):323–330. doi:10.1016/S1474-4422(12)70043-1

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Herdewyn S, Zhao H, Moisse M, Race V, Matthijs G, Reumers J, Kusters B, Schelhaas HJ, van den Berg LH, Goris A, Robberecht W, Lambrechts D, Van Damme P (2012) Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis. Human molecular genetics 21(11):2412–2419. doi:10.1093/hmg/dds055

    Article  CAS  PubMed  Google Scholar 

  16. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K, McDermott CJ, Traynor BJ, Kirby J, Wharton SB, Ince PG, Hardy J, Shaw PJ (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain: a journal of neurology 135(Pt 3):751–764. doi:10.1093/brain/awr365

    Article  Google Scholar 

  17. Fratta P, Mizielinska S, Nicoll AJ, Zloh M, Fisher EM, Parkinson G, Isaacs AM (2012) C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Scientific reports 2:1016. doi:10.1038/srep01016

  18. Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM (2013) Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathol : official J of the Japanese Soc of Neuropathol 33(2):122–133. doi:10.1111/j.1440-1789.2012.01332.x

    Article  Google Scholar 

  19. Troakes C, Maekawa S, Wijesekera L, Rogelj B, Siklos L, Bell C, Smith B, Newhouse S, Vance C, Johnson L, Hortobagyi T, Shatunov A, Al-Chalabi A, Leigh N, Shaw CE, King A, Al-Sarraj S (2012) An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathol : official J of the Japanese Soc of Neuropathol 32(5):505–514. doi:10.1111/j.1440-1789.2011.01286.x

    Article  Google Scholar 

  20. Lin W, Dickson DW (2012) Ultrastructure of ubiquitin-positive, TDP-43-negative neuronal inclusions in cerebral cortex of C9ORF72-linked frontotemporal lobar degeneration/amyotrophic lateral sclerosis. Neuropathol : official J of the Japanese Soc of Neuropathol 32(6):679–681. doi:10.1111/j.1440-1789.2012.01305.x

    Article  Google Scholar 

  21. King A, Al-Sarraj S, Troakes C, Smith BN, Maekawa S, Iovino M, Spillantini MG, Shaw CE (2013) Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta neuropathologica 125(2):303–310. doi:10.1007/s00401-012-1050-0

    Article  CAS  PubMed  Google Scholar 

  22. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobagyi T, Shaw CE (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta neuropathologica 122(6):691–702. doi:10.1007/s00401-011-0911-2

    Article  CAS  PubMed  Google Scholar 

  23. Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, Baker M, Fok A, DeJesus-Hernandez M, Eisen A, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta neuropathologica 123(3):409–417. doi:10.1007/s00401-011-0937-5

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW (2013) Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta neuropathologica 125(2):289–302. doi:10.1007/s00401-012-1048-7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, Safren N, Monteiro MJ, Toledo JB, Elman L, McCluskey L, Irwin DJ, Grossman M, Molina-Porcel L, Lee VM, Trojanowski JQ (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta neuropathologica 123(6):825–839. doi:10.1007/s00401-012-0970-z

    Article  PubMed Central  PubMed  Google Scholar 

  26. Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, Toledo JB, Boller A, Bekisz J, Chandrasekaran K, Wood EM, Shaw LM, Woo JH, Cook PA, Wolk DA, Arnold SE, Van Deerlin VM, McCluskey LF, Elman L, Lee VM, Trojanowski JQ, Grossman M (2013) Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr 84(2):163–169. doi:10.1136/jnnp-2012-303507

    Article  PubMed Central  PubMed  Google Scholar 

  27. Vossel KA, Bien-Ly N, Bernardo A, Rascovsky K, Karydas A, Rabinovici GD, Sidhu M, Huang EJ, Miller BL, Huang Y, Seeley WW (2013) ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease. Neurocase 19(3):295–301. doi:10.1080/13554794.2012.667124

    Article  PubMed Central  PubMed  Google Scholar 

  28. Jang JH, Kwon MJ, Choi WJ, Oh KW, Koh SH, Ki CS, Kim SH (2013) Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 34 (4):1311 e1317-1319. doi:10.1016/j.neurobiolaging.2012.09.004

  29. Zou ZY, Li XG, Liu MS, Cui LY (2013) Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging 34(6):1710.e5–1710.e6. doi:10.1016/j.neurobiolaging.2012.11.018

    CAS  Google Scholar 

  30. Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, Kuzuhara S, Ranum LP, Tamaoki T, Ichikawa Y, Date H, Goto J, Tsuji S (2012) C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Archives of neurology 69(9):1154–1158. doi:10.1001/archneurol.2012.1219

    Article  PubMed  Google Scholar 

  31. Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, Yokoseki A, Eguchi H, Kuwabara S, Nishizawa M, Takahashi H, Onodera O (2013) Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatr 84(4):398–401. doi:10.1136/jnnp-2012-302272

    Article  PubMed  Google Scholar 

  32. Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, Nakamura R, Yoshino H, Yato S, Tamura A, Naito Y, Taniguchi A, Fujita K, Izumi Y, Kaji R, Hattori N, Sobue G (2012) Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 33 (10):2527 e2511-2526. doi:10.1016/j.neurobiolaging.2012.05.011

  33. Ogaki K, Li Y, Takanashi M, Ishikawa K, Kobayashi T, Nonaka T, Hasegawa M, Kishi M, Yoshino H, Funayama M, Tsukamoto T, Shioya K, Yokochi M, Imai H, Sasaki R, Kokubo Y, Kuzuhara S, Motoi Y, Tomiyama H, Hattori N (2013) Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism & related disorders 19(1):15–20. doi:10.1016/j.parkreldis.2012.06.019

    Article  Google Scholar 

  34. Mok KY, Koutsis G, Schottlaender LV, Polke J, Panas M (1851) Houlden H (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobiol Aging 33(8):e1851–1855. doi:10.1016/j.neurobiolaging.2012.02.021

    Google Scholar 

  35. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain: a journal of neurology 135(Pt 3):765–783. doi:10.1093/brain/aws004

    Article  Google Scholar 

  36. Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, Al-Chalabi A, Hardiman O (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet neurology 11(3):232–240. doi:10.1016/S1474-4422(12)70014-5

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Chio A, Calvo A, Mazzini L, Cantello R, Mora G, Moglia C, Corrado L, D'Alfonso S, Majounie E, Renton A, Pisano F, Ossola I, Brunetti M, Traynor BJ, Restagno G, Parals (2012) Extensive genetics of ALS: a population-based study in Italy. Neurology 79(19):1983–1989. doi:10.1212/WNL.0b013e3182735d36

    Article  PubMed  Google Scholar 

  38. Floris G, Borghero G, Cannas A, Di Stefano F, Costantino E, Murru MR, Brunetti M, Restagno G, Traynor BJ, Marrosu MG, Chio A, Marrosu F (2012) Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? Journal of neurology 259(8):1749–1751. doi:10.1007/s00415-012-6444-3

    Article  PubMed  Google Scholar 

  39. Fogel BL, Pribadi M, Pi S, Perlman SL, Geschwind DH, Coppola G (2012) C9ORF72 expansion is not a significant cause of sporadic spinocerebellar ataxia. Mov Disord: official Jof the Mov Disord Soc 27(14):1835–1836. doi:10.1002/mds.25245

    Article  Google Scholar 

  40. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, De Bleecker J, Maes G, Baumer V, Dillen L, Joris G, Cuijt I, Corsmit E, Elinck E, Van Dongen J, Vermeulen S, Van den Broeck M, Vaerenberg C, Mattheijssens M, Peeters K, Robberecht W, Cras P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet neurology 11(1):54–65. doi:10.1016/S1474-4422(11)70261-7

    Article  CAS  PubMed  Google Scholar 

  41. Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C (2013) Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging 34 (5):1519.e1511-1519.e1512

    Google Scholar 

  42. Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker M, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain: a journal of neurology 135(Pt 3):709–722. doi:10.1093/brain/awr354

    Article  Google Scholar 

  43. Huey ED, Nagy PL, Rodriguez-Murillo L, Manoochehri M, Goldman J, Lieberman J, Karayiorgou M, Mayeux R (2013) C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging 34 (4):1309 e1309-1309 e1310. doi:10.1016/j.neurobiolaging.2012.08.011

    Google Scholar 

  44. Ismail A, Cooper-Knock J, Highley JR, Milano A, Kirby J, Goodall E, Lowe J, Scott I, Constantinescu CS, Walters SJ, Price S, McDermott CJ, Sawcer S, Compston DA, Sharrack B, Shaw PJ (2013) Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatr 84(1):79–87. doi:10.1136/jnnp-2012-303326

    Article  PubMed  Google Scholar 

  45. Khan BK, Yokoyama JS, Takada LT, Sha SJ, Rutherford NJ, Fong JC, Karydas AM, Wu T, Ketelle RS, Baker MC, Hernandez MD, Coppola G, Geschwind DH, Rademakers R, Lee SE, Rosen HJ, Rabinovici GD, Seeley WW, Rankin KP, Boxer AL, Miller BL (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatr 83(4):358–364. doi:10.1136/jnnp-2011-301883

    Article  PubMed Central  PubMed  Google Scholar 

  46. Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, Marangi G, Romano A, Marcaccio A, Meleo E, Bisogni G, Rossini PM, Sabatelli M (2012) Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 79(1):66–72. doi:10.1212/WNL.0b013e31825dceca

    Article  CAS  PubMed  Google Scholar 

  47. Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, Puel M, Martinaud O, Deramecourt V, Rivaud-Pechoux S, Millecamps S, Vercelletto M, Couratier P, Sellal F, Pasquier F, Salachas F, Thomas-Anterion C, Didic M, Pariente J, Seilhean D, Ruberg M, Wargon I, Blanc F, Camu W, Michel BF, Berger E, Sauvee M, Thauvin-Robinet C, Mondon K, Tournier-Lasserve E, Goizet C, Fleury M, Viennet G, Verpillat P, Meininger V, Duyckaerts C, Dubois B, Brice A (2013) C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flowchart for genetic testing. J Alzheim Dis: JAD 34(2):485–499. doi:10.3233/JAD-121456

    Google Scholar 

  48. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain: a J of neurology 135(Pt 3):736–750. doi:10.1093/brain/awr361

    Article  Google Scholar 

  49. Majounie E, Abramzon Y, Renton AE, Keller MF, Traynor BJ, Singleton AB (2012) Large C9orf72 repeat expansions are not a common cause of Parkinson's disease. Neurobiol Aging 33 (10):2527 e2521-2522. doi:10.1016/j.neurobiolaging.2012.05.007

  50. Majounie E, Abramzon Y, Renton AE, Perry R, Bassett SS, Pletnikova O, Troncoso JC, Hardy J, Singleton AB, Traynor BJ (2012) Repeat expansion in C9ORF72 in Alzheimer's disease. The New Engl J Med 366(3):283–284. doi:10.1056/NEJMc1113592

    Article  CAS  Google Scholar 

  51. Millecamps S, Boillee S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, Moigneu C, Vandenberghe N, Danel-Brunaud V, Corcia P, Pradat PF, Le Forestier N, Lacomblez L, Bruneteau G, Camu W, Brice A, Cazeneuve C, Leguern E, Meininger V, Salachas F (2012) Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. Am J Med Genet 49(4):258–263. doi:10.1136/jmedgenet-2011-100699

    CAS  Google Scholar 

  52. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta neuropathologica 122(6):673–690. doi:10.1007/s00401-011-0907-y

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D'Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F, Corti S, Ceroni M, Oggioni GD, Lin K, Powell JF, Soraru G, Ticozzi N, Comi GP, D'Alfonso S, Gellera C, Silani V (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33 (10):2528 e2527-2514. doi:10.1016/j.neurobiolaging.2012.06.008

  54. Rollinson S, Halliwell N, Young K, Callister JB, Toulson G, Gibbons L, Davidson YS, Robinson AC, Gerhard A, Richardson A, Neary D, Snowden J, Mann DM (1846) Pickering-Brown SM (2012) Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease. Neurobiol Aging 33(8):e1845–1846. doi:10.1016/j.neurobiolaging.2012.01.109

    Google Scholar 

  55. Rutherford NJ, DeJesus-Hernandez M, Baker MC, Kryston TB, Brown PE, Lomen-Hoerth C, Boylan K, Wszolek ZK, Rademakers R (2012) C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository. Neurology 79(5):482–483. doi:10.1212/WNL.0b013e31826170f1

    Article  PubMed  Google Scholar 

  56. Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurro MR, Volanti P, Marinou K, Salvi F, Corbo M, Giannini F, Battistini S, Penco S, Lunetta C, Quattrone A, Gambardella A, Logroscino G, Simone I, Bartolomei I, Pisano F, Tedeschi G, Conte A, Spataro R, La Bella V, Caponnetto C, Mancardi G, Mandich P, Sola P, Mandrioli J, Renton AE, Majounie E, Abramzon Y, Marrosu F, Marrosu MG, Murru MR, Sotgiu MA, Pugliatti M, Rodolico C, Consortium I, Moglia C, Calvo A, Ossola I, Brunetti M, Traynor BJ, Borghero G, Restagno G (1848) Chio A (2012) C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging 33(8):e1815–1820. doi:10.1016/j.neurobiolaging.2012.02.011

    Google Scholar 

  57. Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, Miller J, Lee Y, Troakes C, Scott KM, Jones A, Gray I, Wright J, Hortobagyi T, Al-Sarraj S, Rogelj B, Powell J, Lupton M, Lovestone S, Sapp PC, Weber M, Nestor PJ, Schelhaas HJ, Asbroek AA, Silani V, Gellera C, Taroni F, Ticozzi N, Van den Berg L, Veldink J, Van Damme P, Robberecht W, Shaw PJ, Kirby J, Pall H, Morrison KE, Morris A, de Belleroche J, Vianney de Jong JM, Baas F, Andersen PM, Landers J, Brown RH Jr, Weale ME, Al-Chalabi A, Shaw CE (2013) The C9ORF72 expansion mutation is a common cause of ALS+/− FTD in Europe and has a single founder. Eur J Hum Genet: EJHG 21(1):102–108. doi:10.1038/ejhg.2012.98

    Article  CAS  PubMed  Google Scholar 

  58. Tsai C-P, Soong B-W, Tu P-H, Lin K-P, Fuh J-L, Tsai P-C, Lu Y-C, Lee IH, Lee Y-C (2012) A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiology of Aging 33 (9):2232.e2211-2232.e2218. doi:10.1016/j.neurobiolaging.2012.05.002

  59. Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, Ghani M, Hernandez I, Ruiz A, Boada M, Moron FJ, Lang AE, Marras C, Bruni A, Colao R, Maletta RG, Puccio G, Rainero I, Pinessi L, Galimberti D, Morrison KE, Moorby C, Stockton JD, Masellis M, Black SE, Hazrati LN, Liang Y, Van Haersma De With J, Fornazzari L, Villagra R, Rojas-Garcia R, Clarimon J, Mayeux R, Robertson J, St George-Hyslop P, Rogaeva E (2012) Investigation of C9orf72 in 4 neurodegenerative disorders. Arch Neurol 69(12):1583–1590. doi:10.1001/archneurol.2012.2016

    Article  PubMed  Google Scholar 

  60. Dombroski BA, Galasko DR, Mata IF, Zabetian CP, Craig UK, Garruto RM, Oyanagi K, Schellenberg GD (2013) C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis–parkinsonism–dementia complex. JAMA neurology 70(6):742–745. doi:10.1001/jamaneurol.2013.1817

    Article  PubMed  Google Scholar 

  61. Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, Myllykangas L, Chio A, Shatunov A, Boeve BF, Boxer AL, DeJesus-Hernandez M, Mackenzie IR, Waite A, Williams N, Morris HR, Simon-Sanchez J, van Swieten JC, Heutink P, Restagno G, Mora G, Morrison KE, Shaw PJ, Rollinson PS, Al-Chalabi A, Rademakers R, Pickering-Brown S, Orrell RW, Nalls MA, Hardy J (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 33 (1):209 e203-208. doi:10.1016/j.neurobiolaging.2011.08.005

  62. Dobson-Stone C, Hallupp M, Bartley L, Shepherd CE, Halliday GM, Schofield PR, Hodges JR, Kwok JB (2012) C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79(10):995–1001. doi:10.1212/WNL.0b013e3182684634

    Article  PubMed  Google Scholar 

  63. Englund E, Gustafson L, Passant U, Majounie E, Renton AE, Traynor BJ, Rohrer JD, Mok K (1850) Hardy J (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. Neurobiol Aging 33(8):e1813–1856. doi:10.1016/j.neurobiolaging.2012.02.019

    Google Scholar 

  64. Garcia-Redondo A, Dols-Icardo O, Rojas-Garcia R, Esteban-Perez J, Cordero-Vazquez P, Munoz-Blanco JL, Catalina I, Gonzalez-Munoz M, Varona L, Sarasola E, Povedano M, Sevilla T, Guerrero A, Pardo J, de Munain AL, Marquez-Infante C, de Rivera FJ, Pastor P, Jerico I, de Arcaya AA, Mora JS, Clarimon J, Gonzalo-Martinez JF, Juarez-Rufian A, Atencia G, Jimenez-Bautista R, Moran Y, Mascias J, Hernandez-Barral M, Kapetanovic S, Garcia-Barcina M, Alcala C, Vela A, Ramirez-Ramos C, Galan L, Perez-Tur J, Quintans B, Sobrido MJ, Fernandez-Torron R, Poza JJ, Gorostidi A, Paradas C, Villoslada P, Larrode P, Capablo JL, Pascual-Calvet J, Goni M, Morgado Y, Guitart M, Moreno-Laguna S, Rueda A, Martin-Estefania C, Cemillan C, Blesa R, Lleo A (2013) Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Human mutation 34(1):79–82. doi:10.1002/humu.22211

    Article  CAS  PubMed  Google Scholar 

  65. Boeve BF, Graff-Radford NR (2012) Cognitive and behavioral features of c9FTD/ALS. Alzheimer's research & therapy 4(4):29. doi:10.1186/alzrt132

    Article  CAS  Google Scholar 

  66. Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee VM, Trojanowski JQ (2012) Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PloS one 7(6):e39216. doi:10.1371/journal.pone.0039216

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Pamphlett R, Cheong PL, Trent RJ, Yu B (2012) Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study. Neuroreport 23(9):556–559. doi:10.1097/WNR.0b013e3283544718

    Article  CAS  PubMed  Google Scholar 

  68. Rohrer JD, Warren JD (2011) Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 24(6):542–549. doi:10.1097/WCO.0b013e32834cd442

    Article  PubMed  Google Scholar 

  69. Calvo A, Moglia C, Canosa A, Cistaro A, Valentini C, Carrara G, Soldano E, Ilardi A, Bersano E, Bertuzzo D, Brunetti M, Ossola I, Restagno G, Chio A (2012) Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene. J Neurol 259(12):2723–2725. doi:10.1007/s00415-012-6640-1

    PubMed  Google Scholar 

  70. Arighi A, Fumagalli GG, Jacini F, Fenoglio C, Ghezzi L, Pietroboni AM, De Riz M, Serpente M, Ridolfi E, Bonsi R, Bresolin N, Scarpini E, Galimberti D (2012) Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J Alzheim Dis JAD 31(2):447–452. doi:10.3233/JAD-2012-120523

    Google Scholar 

  71. Van Langenhove T, van der Zee J, Gijselinck I, Engelborghs S, Vandenberghe R, Vandenbulcke M, De Bleecker J, Sieben A, Versijpt J, Ivanoiu A, Deryck O, Willems C, Dillen L, Philtjens S, Maes G, Baumer V, Van Den Broeck M, Mattheijssens M, Peeters K, Martin JJ, Michotte A, Santens P, De Jonghe P, Cras P, De Deyn PP, Cruts M, Van Broeckhoven C (2013) Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA neurology 70(3):365–373. doi:10.1001/2013.jamaneurol.181

    Article  PubMed  Google Scholar 

  72. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA (2012) Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain: a J Neurol 135(Pt 3):794–806. doi:10.1093/brain/aws001

    Article  Google Scholar 

  73. Whitwell JL, Xu J, Mandrekar J, Boeve BF, Knopman DS, Parisi JE, Senjem ML, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA (2013) Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging 34(2):636–639. doi:10.1016/j.neurobiolaging.2012.03.009

    Article  PubMed Central  PubMed  Google Scholar 

  74. Mahoney CJ, Downey LE, Ridgway GR, Beck J, Clegg S, Blair M, Finnegan S, Leung KK, Yeatman T, Golden H, Mead S, Rohrer JD, Fox NC, Warren JD (2012) Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimer's research & therapy 4(5):41. doi:10.1186/alzrt144

    Article  CAS  Google Scholar 

  75. Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, DeJesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Seeley W, Miller BL, Boxer AL (2012) Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 79(10):1002–1011. doi:10.1212/WNL.0b013e318268452e

    Article  PubMed  Google Scholar 

  76. Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF (2013) The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET Trumps syndrome. Neurocase. doi:10.1080/13554794.2012.732090

    Google Scholar 

  77. Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta neuropathologica 118(3):349–358. doi:10.1007/s00401-009-0547-7

    Article  PubMed Central  PubMed  Google Scholar 

  78. Downey LE, Mahoney CJ, Rossor MN, Crutch SJ, Warren JD (2012) Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion. Alzheimer's research & therapy 4(5):42. doi:10.1186/alzrt145

    Article  CAS  Google Scholar 

  79. Savica R, Adeli A, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Whitwell J, Jack CR, Lowe V, Petersen RC, Boeve BF (2012) Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol 69(9):1164–1169. doi:10.1001/archneurol.2012.772

    Article  PubMed Central  PubMed  Google Scholar 

  80. Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, Mayeux R, Tierney MC, Kapogiannis D, Jicha GA, Murrell JR, Ghetti B, Wassermann EM, Grafman J, Hardy J, Huey ED (1850) Momeni P (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging 33(8):e1851–1811. doi:10.1016/j.neurobiolaging.2012.02.017

    Google Scholar 

  81. Dobson-Stone C, Hallupp M, Loy CT, Thompson EM, Haan E, Sue CM, Panegyres PK, Razquin C, Seijo-Martinez M, Rene R, Gascon J, Campdelacreu J, Schmoll B, Volk AE, Brooks WS, Schofield PR, Pastor P, Kwok JB (2013) C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PloS one 8(2):e56899. doi:10.1371/journal.pone.0056899

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  82. Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, Fumagalli GG, Del Bo R, Bruni AC, Anfossi M, Clodomiro A, Cupidi C, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Bessi V, Marcone A, Cerami C, Cappa SF, Filippi M, Agosta F, Magnani G, Comi G, Franceschi M, Rainero I, Giordana M, Rubino E, Ferrero P, Rogaeva E, Xi Z, Confaloni A, Piscopo P, Bruno G, Talarico G, Cagnin A, Clerici F, Dell'osso B, Comi GP, Altamura AC, Mariani C, Scarpini E (2013) Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatr. doi:10.1016/j.biopsych.2013.01.031

    Google Scholar 

  83. Morris HR, Waite AJ, Williams NM, Neal JW, Blake DJ (2012) Recent advances in the genetics of the ALS–FTLD complex. Curr Neurol Neurosci Rep 12(3):243–250. doi:10.1007/s11910-012-0268-5

    Article  CAS  PubMed  Google Scholar 

  84. Daoud H, Suhail H, Sabbagh M, Belzil V, Szuto A, Dionne-Laporte A, Khoris J, Camu W, Salachas F, Meininger V, Mathieu J, Strong M, Dion PA, Rouleau GA (2012) C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia. Arch Neurol 69(9):1159–1163. doi:10.1001/archneurol.2012.377

    Article  PubMed  Google Scholar 

  85. Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J (2012) Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat. Frontiers in neurology 3:136. doi:10.3389/fneur.2012.00136

  86. Wallon D, Rovelet-Lecrux A, Deramecourt V, Pariente J, Auriacombe S, Le Ber I, Schraen S, Pasquier F, Campion D, Hannequin D (2012) Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. Journal of Alzheimer's disease: JAD 32(1):19–22. doi:10.3233/JAD-2012-120877

    CAS  PubMed  Google Scholar 

  87. Harms M, Benitez BA, Cairns N, Cooper B, Cooper P, Mayo K, Carrell D, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, Mayeux R, Chakraverty S, Goate AM, Cruchaga C, for the NIALNFSC (2013) C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA neurology:1–6. doi:10.1001/2013.jamaneurol.537

  88. Synofzik M, Biskup S, Leyhe T, Reimold M, Fallgatter AJ, Metzger F (2012) Suicide attempt as the presenting symptom of C9orf72 dementia. The American journal of psychiatry 169(11):1211–1213. doi:10.1176/appi.ajp.2012.12060733

    Article  PubMed  Google Scholar 

  89. Martikainen MH, Gardberg M, Jansson L, Roytta M, Rinne JO, Kaasinen V (2013) Brain (18)F-FDG and (11)C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion. Neurocase. doi:10.1080/13554794.2012.741252

    Google Scholar 

  90. Sommer IE, Aleman A, Slotema CM, Schutter DJ (2012) Transcranial stimulation for psychosis: the relationship between effect size and published findings. The American journal of psychiatry 169(11):1211. doi:10.1176/appi.ajp.2012.12060741

    Article  PubMed  Google Scholar 

  91. O'Dowd S, Curtin D, Waite AJ, Roberts K, Pender N, Reid V, O'Connell M, Williams NM, Morris HR, Traynor BJ, Lynch T (2012) C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Movement disorders: official journal of the Movement Disorder Society 27(8):1072–1074. doi:10.1002/mds.25022

    Article  Google Scholar 

  92. Lesage S, Le Ber I, Condroyer C, Broussolle E, Gabelle A, Thobois S, Pasquier F, Mondon K, Dion PA, Rochefort D, Rouleau GA, Durr A, Brice A, French Parkinson's Disease Genetics Study G (2013) C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain: a journal of neurology 136(Pt 2):385–391. doi:10.1093/brain/aws357

    Google Scholar 

  93. Yeh TH, Lai SC, Weng YH, Kuo HC, Wu-Chou YH, Huang CL, Chen RS, Chang HC, Traynor B, Lu CS (2013) Screening for C9orf72 repeat expansions in parkinsonian syndromes. Neurobiol Aging 34 (4):1311 e1313-1314. doi:10.1016/j.neurobiolaging.2012.09.002

  94. Daoud H, Noreau A, Rochefort D, Paquin-Lanthier G, Gauthier MT, Provencher P, Pourcher E, Dupre N, Chouinard S, Jodoin N, Soland V, Fon EA, Dion PA, Rouleau GA (2013) Investigation of C9orf72 repeat expansions in Parkinson's disease. Neurobiol Aging 34(6):1710.e7–1710.e9. doi:10.1016/j.neurobiolaging.2012.11.025

  95. Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American journal of human genetics 92(3):345–353. doi:10.1016/j.ajhg.2013.01.011

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  96. Lindquist S, Duno M, Batbayli M, Puschmann A, Braendgaard H, Mardosiene S, Svenstrup K, Pinborg L, Vestergaard K, Hjermind L, Stokholm J, Andersen B, Johannsen P, Nielsen J (2013) Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clinical genetics 83(3):279–283. doi:10.1111/j.1399-0004.2012.01903.x

    Article  CAS  PubMed  Google Scholar 

  97. van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, de Bakker PI, Veldink JH, van den Berg LH (2012) Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Human molecular genetics 21(17):3776–3784. doi:10.1093/hmg/dds199

    Article  PubMed  Google Scholar 

  98. van Blitterswijk M, van Es MA, Koppers M, van Rheenen W, Medic J, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH (2012) VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol Aging 33 (12):2950 e2951-2954. doi:10.1016/j.neurobiolaging.2012.07.004

  99. Patani R, Sibley CR, Chandran S, Ule J (2012) Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases. Brain research 1462:129–138. doi:10.1016/j.brainres.2011.12.057

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by grants from the National Natural Science Foundation of China (81000544 and 81171209); the Shandong Provincial Natural Science Foundation, China (ZR2010HQ004 and ZR2011HZ001); and the Shandong Provincial Outstanding Medical Academic Professional Program.

Conflict of Interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Dalian, China

    Ying Liu, Jing Zhou & Lan Tan

  2. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China

    Jin-Tai Yu, Yu Zong & Lan Tan

Authors
  1. Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin-Tai Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Zong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jin-Tai Yu or Lan Tan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Yu, JT., Zong, Y. et al. C9ORF72 Mutations in Neurodegenerative Diseases. Mol Neurobiol 49, 386–398 (2014). https://doi.org/10.1007/s12035-013-8528-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-013-8528-1

Keywords

Search

Navigation